AAAAAA
Results:
1-7
|
Results: 7
Authors:
LI SR
YANG Q
KOLLER E
KURTARAN A
BISCHOF C
LEIMER M
RAUSCHA F
PIDLICH J
VIRGOLINI I
Citation: Sr. Li et al., MODIFIED LDL DECREASES THE BINDING OF PROSTAGLANDIN E-2, I-2, AND E-1ONTO MONOCYTES IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 17(10), 1997, pp. 2066-2073
Authors:
HIRSCHL MM
GWECHENBERGER M
BINDER T
BINDER M
GRAF S
STEFENELLI T
RAUSCHA F
LAGGNER AN
SOCHOR H
Citation: Mm. Hirschl et al., ASSESSMENT OF MYOCARDIAL INJURY BY SERUM TUMOR-NECROSIS-FACTOR-ALPHA MEASUREMENTS IN ACUTE MYOCARDIAL-INFARCTION, European heart journal, 17(12), 1996, pp. 1852-1859
Authors:
RAUSCHA F
SCHNEIDER S
GEPPERT A
DOMANOVITS H
HRSKA F
LAGGNER A
WEBER H
MAUER G
Citation: F. Rauscha et al., CARDIOPULMONARY-RESUSCITATION TRAINING - A MUST FOR ALL EMPLOYEES, Circulation, 94(8), 1996, pp. 2080-2080
Authors:
HUBER K
WEIN W
HORNYKEWYCZ S
ZEHETGRUBER M
RAUSCHA F
Citation: K. Huber et al., ANTIHYPERTENSIVE THERAPY AND CORONARY-ART ERY DISEASE - THE ROLE OF INFLUENCING COEXISTING CARDIOVASCULAR RISK-FACTORS, Acta medica austriaca, 22(3), 1995, pp. 48-51
Authors:
FITSCHA P
RAUSCHA F
OGRADY J
KEILER A
SINZINGER H
Citation: P. Fitscha et al., ISRADIPINE INHIBITS MITOTIC AND PROLIFERATIVE ACTIVITY IN THE ARTERIAL NAIL, Experimental and toxicologic pathology, 46(1), 1994, pp. 75-80
Authors:
HUBER K
BECKMANN R
RAUSCHA F
PROBST P
KAINDL F
BINDER BR
Citation: K. Huber et al., THE ROLE OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN FAILURE OF THROMBOLYTIC THERAPY WITH RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR, Zeitschrift fur Kardiologie, 82, 1993, pp. 195-200
Authors:
VIRGOLINI I
KOLLER E
LI SR
YANG Q
BANYAI M
RAUSCHA F
PIDLICH J
PIRKER W
SINZINGER H
Citation: I. Virgolini et al., ETOFIBRATE INCREASES BINDING OF LOW AND HIGH-DENSITY-LIPOPROTEIN TO HUMAN PLATELETS OF PATIENTS WITH TYPE-II HYPERLIPOPROTEINEMIA, Atherosclerosis, 102(2), 1993, pp. 217-226
Risultati:
1-7
|